EuroPCR 2016 Highlights: Coronary Interventions
With a week rich in late breaking trials, educational sessions and live cases, T. Cuisset, A. Baumbach and M. Haude share what inspired them at EuroPCR. Do the results of the LEADERS-FREE trial spell the end of bare metal stents? How do our international colleagues find balance between their ability to offer treatment or a specific device? What are the rewards of such vibrant EuroPCR features as the “complications” sessions?